The global combat dressing market size was valued at USD 1.57 billion in 2025 and is projected to grow from USD 1.66 billion in 2026 to USD 2.56 billion by 2034, registering a CAGR of 5.60% during the forecast period (2026-2034). North America dominated the combat dressing market with a share of 43.2% in 2025.
A combat dressing is a sterile medical dressing designed to control bleeding, protect wounds, and support emergency treatment of injuries sustained during military operations, combat situations, or other trauma-related incidents. Combat dressings are tracked under HSN Code 3005 (wadding, gauze, bandages, and similar wound dressings) and SIC Code 3841 (surgical and medical instruments and apparatus).
The combat dressing market demand is driven by the need for rapid wound management in military operations, a focus on battlefield trauma care, and the procurement of emergency medical supplies for defense personnel. Medical device manufacturers are developing combat dressings with hemostatic materials, improved absorption, and compact designs to support faster bleeding control in field conditions.
Download a Free Sample To learn more about this report,
Development of Chitosan Based Hemostatic Dressings for Rapid Bleeding Control
The combat dressing market analysis shows a shift toward hemostatic dressings that use chitosan to promote blood clot formation at wound sites. Chitosan interacts with blood components to support clot formation, which makes it useful in dressings for traumatic injuries and severe bleeding. These products are particularly relevant to military medics and emergency responders who require rapid bleeding control in field conditions.
Integration of Wound Packing Materials with Compact Trauma Dressings
Combat dressing manufacturers are refining compact wound packing gauzes and compressed dressings designed for deep wounds caused by penetrating trauma. These products allow medical personnel to place dressing material directly into wound cavities before applying pressure to control bleeding.
Supply chain disruptions are expected to have a high impact on the combat dressing market share due to their direct exposure to medical-grade gauze, kaolin, and chitosan-based hemostatic materials. A capacity-constrained recovery is a suitable assumption because limited supplies of specialized hemostatic materials and delays in production can restrict the availability of combat dressings. These constraints could reduce the growth rate from 5.60% to 4.10%, a decline of 1.50 percentage points. As supply conditions normalize, the combat dressing market growth is expected to gradually return to 5.60%.
The combat dressing market forecasts investment in hemostatic dressings, advanced wound care materials, and battlefield bleeding-control technologies. In September 2026, MediWound received an additional USD 3.3 million from the United States Department of War to develop a room-temperature-stable formulation of NexoBrid for battlefield burn treatment.
Demand for Portable Combat Medical Supplies and Focus on Improving Survival Rates Among Wounded Soldiers Drives Market
Military personnel require compact and lightweight medical supplies that can be carried easily during combat operations without restricting mobility. Combat dressings provide convenient wound coverage and help control bleeding in field conditions, making them essential components of individual first-aid kits. The emphasis on portable trauma care equipment is encouraging demand for compact, durable, and easy-to-use solutions, contributing to the combat dressing market growth.
Military healthcare providers are prioritizing rapid bleeding control and immediate wound management to improve survival following battlefield injuries. Combat dressings help cover wounds and apply pressure to control bleeding until advanced medical treatment becomes available.
Strict Military Procurement Standards and Battlefield Performance Limitations Restrain Market Expansion
Combat dressings must meet strict military and medical requirements for bleeding control, durability, and safe use under emergency conditions. Product testing, certification, and procurement approval can extend purchasing timelines and increase compliance costs, which may limit market entry for smaller manufacturers.
Combat dressings may face performance limitations in cases of severe arterial bleeding, deep wounds, or injuries in difficult anatomical locations. The need for additional medical interventions in such cases can restrict the effectiveness of individual dressing products and increase the importance of specialized training and alternative hemorrhage-control methods.
Combat Dressings for Prolonged Field Evacuation and Wound Assessment Training Kits Open New Avenues for Market Players
Prolonged field evacuation presents a specialized opportunity for combat dressing manufacturers. Injured personnel may wait for evacuation when combat conditions or remote terrain restrict access to medical teams. Manufacturers can develop dressings with extended wear performance, secure adhesion under heavy movement, and packaging that remains usable after exposure to dust, moisture, and temperature changes.
Wound assessment training kits offer another opportunity for combat dressing suppliers. Military medical teams need realistic practice with different wound types before deployment. Companies can bank on developing training kits that pair combat dressings with reusable wound simulators, allowing personnel to practise pressure application, wound packing, and dressing placement without using live medical supplies.
Hemostatic dressings are likely to grow at a rate of 6.4% during the forecast period, driven by the need for rapid bleeding control and clot formation during battlefield injuries and emergency trauma care.
The non-hemostatic dressings segment is projected to register a CAGR of 4.3% during the forecast period, supported by their use in wound coverage, protection of injured tissue, and routine bleeding management across military and civilian healthcare settings.
Request Customizationto receive a tailored report.
Gauze held the leading position with a share of 39.5% in 2025, reflecting its widespread use in wound packing, bleeding control, and emergency trauma care. Its versatility and ease of application support its use across military and civilian emergency settings.
Pressure bandages are expected to grow at a CAGR of 6.2% during the forecast period, driven by their role in applying sustained pressure to wounds and controlling bleeding during battlefield emergencies and prehospital care.
Defense forces accounted for a dominant share of 46.8% in 2025, reflecting the need for effective bleeding control supplies during combat operations, military training, and battlefield casualty management. Combat dressing availability supports rapid first aid before injured personnel reach advanced medical facilities.
Emergency medical services are anticipated to record a CAGR of 6.3% during the forecast period, fueled by the need for rapid bleeding control at accident sites and during patient transport. The use of combat dressings in prehospital trauma care supports their adoption by emergency medical teams.
Speak to an Analystto discuss market opportunities.
The North America combat dressing market is accounted for a dominant share of 43.2% in 2025.
US personnel rely on tourniquets as essential tools for controlling severe bleeding during battlefield injuries. Department of Defense’s Committee on Tactical Combat Casualty Care evaluates and recommends tourniquets for military trauma care. These requirements create scope for manufacturers to develop and supply reliable, easy-to-use tourniquets that meet military trauma care standards.
Emergency medical supplies form an essential part of Canada’s combat dressing market, particularly for battlefield injuries and field operations. The Canadian Department of National Defence awarded CTOMS a contract for medical supplies and equipment for military use at Meaford, Ontario. This procurement highlights the need for dependable trauma care products and gives suppliers scope to serve Canada’s defense medical supply requirements.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific combat dressing market will expand to 6.5% CAGR, showcasing the fastest-growing regional growth.
Shenzhen Institute of Advanced Technology developed a bacterial cellulose dressing with human-derived thrombin to improve blood clotting and wound healing. The dressing achieved bleeding control within one minute in laboratory and animal testing, highlighting the potential of bioengineered materials for severe trauma care. This progress helps medical suppliers develop next-generation wound dressings that offer faster bleeding control and improved trauma care.
The combat dressing market in India reflects the role of collaboration between the Armed Forces Medical College and the Indian Institute of Science to develop combat medical technologies for troops in high-risk areas, with a focus on specialized medical equipment and advanced wound care research. This collaboration translates biomedical research into improved trauma dressings and bleeding-control products.
Japan’s Ministry of Defense announced plans to strengthen frontline first-aid capabilities, coordinate with civilian medical institutions for trauma-care training, and improve stockpiling of medical equipment and supplies. The Ground Self-Defense Force issued a procurement notice in September 2026 for 657 wound chest-seal dressings, reflecting direct procurement demand for combat wound-care products.
Europe's combat dressing market is expected to experience a growth rate of 5.1% during the forecast period.
British Army Tactical Combat Casualty Care training prepares personnel to use personal medical packs, haemostatic dressings, and tourniquets to control severe bleeding before evacuation. This emphasis on lightweight, ready-to-use equipment highlights the role of compact wound care products in military operations where immediate medical support may not be available.
Germany’s Federal Office of Bundeswehr Equipment issued a procurement notice for Z-fold hemostatic dressings and training variants, reflecting the military’s need for wound-control products and practical casualty-care preparation. The use of specialized gauze creates a clear for manufacturers that serve military medical units with products suited to rapid trauma response.
The Latin America combat dressing market is anticipated to record a growth rate of 5.7% during the forecast period. The Ministry of National Defense has incorporated tactical military medicine into specialist training at its Special Forces Training Center, with modules on combat casualty care, trauma support, and aeromedical evacuation. Brazil’s Armed Forces Hospital conducted a pilot tactical pre-hospital care training program for personnel from the Army, Navy, and Air Force, with practical instruction in trauma assessment and casualty evacuation.
The Middle East & Africa combat dressing market is projected to achieve a growth rate of 6.3% during the forecast period. The UAE focuses on military medical supplies and emergency response capabilities, supporting demand for hemostatic dressings, pressure dressings, and specialized wound care products for military personnel and first responders. The South African National Defence Force highlighted the role of its military healthcare professionals in delivering medical services, demonstrating the reach of its military medical capabilities beyond major healthcare centers.
The combat dressing market competitive landscape includes established medical device manufacturers, tactical medical suppliers, and specialized hemostatic dressing providers. Key players such as Teleflex Incorporated, North American Rescue, LLC, TacMed, Safeguard Medical, and Medtrade Products are estimated to account for over 40% of the global combat dressing market share.
Established players compete through bleeding control effectiveness, wound care performance, product reliability, and suitability for military and emergency medical settings. Emerging players in the combat dressing market ecosystem focus on providing hemostatic dressings, compact trauma kits, and field-ready wound care solutions.
September 2026: Cresilon launched the next-generation TRAUMAGEL hemostatic gel in a compact syringe format.
August 2026: The United States Navy's Naval Medical Research Command advanced the XSTAT P15 hemorrhage-control device toward operational use.
July 2026: Cresilon reported clinical case findings on TRAUMAGEL for hemorrhage control and tourniquet management in traumatic injuries, highlighting its potential role in prolonged field care.
June 2026: The Indian Army completed a procurement process for combat compression bandages, chitosan-based hemostatic dressings, and chest seal dressings.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Angiography Imaging Systems Market Size, Forecast, Opportunities, 2034
Bariatric Transport Wheelchairs Market Size, Forecast, Demand, Opportunities, 2034
Sleep Market Size, Share, Growth, Opportunities, Analysis, 2034
General Surgical Devices Market Size, Share, Growth, Analysis, 2034
Adult Pediatric Hemoconcentrators Market Size, Opportunities, 2034
Handheld Backscatter X-Ray Devices Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com